Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 1
Abstracts From the Literature
A HarrisMartin Interview with Christopher A. Seeger, Esq.
Ala. Plaintiff Can Pursue Claims Against Merck Sales Reps, Judge Remands Case
Arthritis Drugs - Issue: 2
Ala. Woman's Third Attempt to Add Non-Diverse Defendants to Vioxx Suit Denied by Judge
Damages Sought For Celebrex-Related Injuries Do Not Exceed Jurisdictional Limit, Woman Claims
Arthritis Drugs - Issue: 1
Drug Manufacturer Responds to Claims in Remicase Injury Case
Former Running Back Settles Suit Against Arthritis Drugs Makers
Judge Addresses Discovery Issues at First Vioxx Mass Tort Status Conference
